Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use
Seminars in Liver Disease, 10/16/09
Raja K et al. – Amiodarone is a lipophilic drug that concentrates in the liver and usually, over a period of time, leads to toxicity related to drug accumulation. There is marked histological similarity between amiodarone–induced liver disease and alcoholic and nonalcoholic steatohepatitis. The clinical manifestations of amiodarone–induced hepatotoxicity and the mechanism of toxicity are also discussed.
Related Articles
Liver disease: Early signs you may be missing
APCToday, 10/22/09
Relevance Score: 70%
Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09
Relevance Score: 68%
Atypical esophageal vascular lesions observed in liver cirrhosis
Diseases of the Esophagus, 10/27/09
Relevance Score: 67%
Non-invasive evaluation of liver cirrhosis using ultrasound
Clinical Radiology, 10/19/09
Relevance Score: 67%
Oxidative stress modulation by Rosmarinus officinalis in CCl4-induced liver cirrhosis
Phytotherapy Research, 10/19/09
Relevance Score: 67%
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Hyperuricemia, Gout, and Renal Function After Liver Transplantation
Transplantation, 12/18/09
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/18/09
Air cavitogram as investigative modality for Amoebic Liver Abscess
The Internet Journal of Gastroenterology, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/18/09
New modalities and paradigms for sedation: new sedation agents
Techniques in Gastrointestinal Endoscopy , 12/18/09
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


